Archives
Pfizer to end merger deal with Allergan as new rules frighten corporate inversions
Pfizer, a US-based drug company, is said to dismiss its merger deal with Allergan. The US drugmaker wants to quit from the $160 billion merger deal since Washington authorities set new rules, making corporate inversions harder.
Asian shares climb little higher on Wednesday
Stock prices in the Asian markets gained on Wednesday following a steep decline in the past session. Asia-Pacific shares excluding Japan in MSCI increased 0.1% during the early trading session after a 1.6% fall in the previous day.
Societe Generale says it obeys all rules fighting tax evasion and fraud
Societe Generale said that it stood by all the rules of its operating nations. The bank confirmed that it no longer detained any establishments in the process in the Non-Cooperative Countries and Territories.
Lumber Liquidators wins the California lawsuit
Lumber Liquidators won a civil case, which had alleged the company for violating a state law in California that urges companies to report warnings regarding the possible harmful substances in their products.